Advanced Micro Devices (AMD) announced new details on Thursday about its next-generation AI chips, the Instinct MI400 series, ...

AMD's next-generation Instinct MI500 will be mass-produced on TSMC's new N2P process node, will directly compete with NVIDIA's next-gen AI hardware.

The MI400X Series also will be at the heart of AMD’s new Helios system, which Su described as “a rack-scale, unified system” ...

AMD has introduced the Ryzen 5 5500X3D for Latin American customers. The new chip is AMD's lowest-end Ryzen 5000X3D part, ...

AMD issued a raft of news at their Advancing AI 2025 event this week, an update on the company’s response to NVIDIA's 90-plus ...

AMD has revealed its Instinct MI400 series AI chips, designed for rack-scale systems and set to compete with Nvidia's ...

AMD’s rack-scale AI infrastructure, featuring MI350 Series GPUs, 5th Gen EPYC processors, and Pensando Pollara NICs, is already being deployed by hyperscalers including Oracle Cloud Infrastructure, ...

AM4 is the CPU socket that just refuses to die. Nearly a decade after first making its way into motherboards, AMD is still ...

Perfect for small to mid-sized businesses and IT service providers, these processors offer the right mix of power and ...

Advanced Micro Devices and SMTC are well-known players in the semiconductor market. Let's find out which one is a better ...

LYTENAVA™ (bevacizumab gamma) is the first ophthalmic formulation of bevacizumab to receive European Commission and MHRA Marketing Authorization for the treatment of wet AMD. Outlook Therapeutics ...

Outlook Therapeutics commenced commercial launch of LYTENAVA™ (bevacizumab gamma) in Germany and the UK as a treatment for wet AMD. In the United States, ONS-5010/LYTENAVA™ is ...